Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Bellicum Pharmaceuticals Inc Clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer. |
United States | N/A |
||
|
|
Miragen Therapeutics Inc Ddeveloper of cardiovascular and muscle disease therapeutics based on microRNA biology. |
United States | 1 Apr 2012 | Series B Initial investment. Round participant. Active |